Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
49.9M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
43.9M
-
Shares change
-
+2.03M
-
Total reported value, excl. options
-
$730M
-
Value change
-
+$34M
-
Number of buys
-
40
-
Number of sells
-
-27
-
Price
-
$16.63
Significant Holders of HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) as of Q1 2024
85 filings reported holding HLVX - HilleVax, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.9M shares
of 49.9M outstanding shares and own 88.05% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (9.78M shares), TAKEDA PHARMACEUTICAL CO LTD (6.72M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4M shares), T. Rowe Price Investment Management, Inc. (3.06M shares), Deep Track Capital, LP (2.57M shares), VR Adviser, LLC (2.08M shares), FRANKLIN RESOURCES INC (1.85M shares), Carlyle Group Inc. (1.84M shares), BlackRock Inc. (1.8M shares), and VANGUARD GROUP INC (1.36M shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.